Genetron Holdings Stock Fundamentals

GTHDelisted Stock  USD 0.94  0.02  2.08%   
Genetron Holdings fundamentals help investors to digest information that contributes to Genetron Holdings' financial success or failures. It also enables traders to predict the movement of Genetron Stock. The fundamental analysis module provides a way to measure Genetron Holdings' intrinsic value by examining its available economic and financial indicators, including the cash flow records, the balance sheet account changes, the income statement patterns, and various microeconomic indicators and financial ratios related to Genetron Holdings stock.
  
This module does not cover all equities due to inconsistencies in global equity categorizations. Continue to Equity Screeners to view more equity screening tools.

Genetron Holdings Company Profit Margin Analysis

Genetron Holdings' Profit Margin measures overall efficiency of a company and shows its ability to withstand competition as well as defend against adverse conditions such as rising costs, falling prices, decline in sales or management distress. Profit margin tells investors how well the company executes on its overall pricing strategies as well as how effective the company in controlling its costs.

Profit Margin

 = 

Net Income

Revenue

X

100

More About Profit Margin | All Equity Analysis

Current Genetron Holdings Profit Margin

    
  (1.24) %  
Most of Genetron Holdings' fundamental indicators, such as Profit Margin, are part of a valuation analysis module that helps investors searching for stocks that are currently trading at higher or lower prices than their real value. If the real value is higher than the market price, Genetron Holdings is considered to be undervalued, and we provide a buy recommendation. Otherwise, we render a sell signal.
In a nutshell, Profit Margin indicator shows the amount of money the company makes from total sales or revenue. It can provide a good insight into companies in the same sector, as well as help to identify trends of a company from year to year.
Competition

Based on the latest financial disclosure, Genetron Holdings has a Profit Margin of -1.2424%. This is 88.92% lower than that of the Biotechnology sector and 89.3% lower than that of the Health Care industry. The profit margin for all United States stocks is 2.17% lower than that of the firm.

Genetron Holdings Fundamental Drivers Relationships

Comparative valuation techniques use various fundamental indicators to help in determining Genetron Holdings's current stock value. Our valuation model uses many indicators to compare Genetron Holdings value to that of its competitors to determine the firm's financial worth. You can analyze the relationship between different fundamental ratios across Genetron Holdings competition to find correlations between indicators driving Genetron Holdings's intrinsic value. More Info.
Genetron Holdings is rated below average in return on equity category among its peers. It is rated below average in return on asset category among its peers . The reason why the comparable model can be used in almost all circumstances is due to the vast number of multiples that can be utilized, such as the price-to-earnings (P/E), price-to-book (P/B), price-to-sales (P/S), price-to-cash flow (P/CF), and many others. The P/E ratio is the most commonly used of these ratios because it focuses on the Genetron Holdings' earnings, one of the primary drivers of an investment's value.

Genetron Profit Margin Peer Comparison

Stock peer comparison is one of the most widely used and accepted methods of equity analyses. It analyses Genetron Holdings' direct or indirect competition against its Profit Margin to detect undervalued stocks with similar characteristics or determine the stocks which would be a good addition to a portfolio. Peer analysis of Genetron Holdings could also be used in its relative valuation, which is a method of valuing Genetron Holdings by comparing valuation metrics of similar companies.
Genetron Holdings is currently under evaluation in profit margin category among its peers.

Genetron Fundamentals

About Genetron Holdings Fundamental Analysis

The Macroaxis Fundamental Analysis modules help investors analyze Genetron Holdings's financials across various querterly and yearly statements, indicators and fundamental ratios. We help investors to determine the real value of Genetron Holdings using virtually all public information available. We use both quantitative as well as qualitative analysis to arrive at the intrinsic value of Genetron Holdings based on its fundamental data. In general, a quantitative approach, as applied to this company, focuses on analyzing financial statements comparatively, whereas a qaualitative method uses data that is important to a company's growth but cannot be measured and presented in a numerical way.
Please read more on our fundamental analysis page.
Genetron Holdings Limited, a precision oncology company, engages in the cancer molecular profiling, and harnessing technologies in molecular biology and data science for cancer treatment. Genetron Holdings Limited was founded in 2015 and is headquartered in Beijing, the Peoples Republic of China. Genetron Holdings operates under Diagnostics Research classification in the United States and is traded on NASDAQ Exchange. It employs 1154 people.

Currently Active Assets on Macroaxis

Check out Risk vs Return Analysis to better understand how to build diversified portfolios. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in estimate.
You can also try the Portfolio Center module to all portfolio management and optimization tools to improve performance of your portfolios.

Other Consideration for investing in Genetron Stock

If you are still planning to invest in Genetron Holdings check if it may still be traded through OTC markets such as Pink Sheets or OTC Bulletin Board. You may also purchase it directly from the company, but this is not always possible and may require contacting the company directly. Please note that delisted stocks are often considered to be more risky investments, as they are no longer subject to the same regulatory and reporting requirements as listed stocks. Therefore, it is essential to carefully research the Genetron Holdings' history and understand the potential risks before investing.
Instant Ratings
Determine any equity ratings based on digital recommendations. Macroaxis instant equity ratings are based on combination of fundamental analysis and risk-adjusted market performance
Bond Analysis
Evaluate and analyze corporate bonds as a potential investment for your portfolios.
Latest Portfolios
Quick portfolio dashboard that showcases your latest portfolios
Sync Your Broker
Sync your existing holdings, watchlists, positions or portfolios from thousands of online brokerage services, banks, investment account aggregators and robo-advisors.
Piotroski F Score
Get Piotroski F Score based on the binary analysis strategy of nine different fundamentals
Portfolio Suggestion
Get suggestions outside of your existing asset allocation including your own model portfolios
USA ETFs
Find actively traded Exchange Traded Funds (ETF) in USA
Correlation Analysis
Reduce portfolio risk simply by holding instruments which are not perfectly correlated
Investing Opportunities
Build portfolios using our predefined set of ideas and optimize them against your investing preferences